| Joel E Washinsky, MD | |
|
3012 S Durango Dr, Ste. 1, Las Vegas, NV 89117-9186 | |
| (702) 366-0640 | |
| (702) 366-9075 |
| Full Name | Joel E Washinsky |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 3012 S Durango Dr, Las Vegas, Nevada |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003883315 | NPI | - | NPPES |
| 100502845 | Medicaid | NV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 5955 (Nevada) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Joel E Washinsky, MD 3012 S Durango Dr, Ste. 2, Las Vegas, NV 89117-9186 Ph: (702) 366-1655 | Joel E Washinsky, MD 3012 S Durango Dr, Ste. 1, Las Vegas, NV 89117-9186 Ph: (702) 366-0640 |
News Archive
UCB announced today that the U.S. Food and Drug Administration (FDA) has approved Keppra XR (levetiracetam extended-release tablets) for use as an add-on to other antiepileptic treatments for people with partial onset seizures who are 16 years of age and older. Keppra XR is expected to be available in U.S. pharmacies at the end of September 2008.
iPierian, Inc., a biopharmaceutical company focused on changing the paradigm of drug discovery and development through the application of cellular reprogramming, today announced that the Intellectual Property Office in the United Kingdom has issued a Notification of Grant to iPierian for UK patent No. GB2450603, its first patent related to induced pluripotent stem cell (iPSC) technology.
A study of adults in the United States finds that - broadly speaking - the older you are, the more concerned you are about COVID-19, and the more steps you take to reduce your risk from COVID-19.
The number of doctors and advance practitioners in the United States who focus on nursing home care rose by more than a third between 2012 and 2015, according to a new study published today in JAMA from researchers at the Perelman School of Medicine at the University of Pennsylvania.
The Lancet Oncology published this week findings from a study, which showed that the new oral therapy IMNOVID®▼ (pomalidomide), used in combination with low-dose dexamethasone demonstrated a significant survival advantage over high-dose dexamethasone alone, in patients with relapsed and refractory multiple myeloma (rrMM).1
› Verified 2 days ago
Dr. Arshi A. Quadeer, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2545 S Bruce St Ste 200, Las Vegas, NV 89169 Phone: 702-732-2438 Fax: 702-737-5043 | |
Cherie Lin, D.O. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 3006 S Maryland Pkwy, Suite 400, Las Vegas, NV 89109 Phone: 702-369-5582 Fax: 702-369-1533 | |
Michael M Lee, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1800 W Charleston Blvd, Las Vegas, NV 89102 Phone: 702-921-6823 Fax: 702-549-5240 | |
Henry Palangdao Igid, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 653 N Town Center Dr Ste 402, Las Vegas, NV 89144 Phone: 702-243-7200 Fax: 702-243-7235 | |
Ian Adrian Fanoga Frani, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1800 W Charleston Blvd, Las Vegas, NV 89102 Phone: 702-383-2000 Fax: 702-383-3875 | |
Sein Tun, DO Internal Medicine Medicare: Medicare Enrolled Practice Location: 620 Shadow Ln, Las Vegas, NV 89106 Phone: 702-388-4000 | |
Berge Jack Dadourian, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 400 S Rampart Blvd, Suite 240, Las Vegas, NV 89145 Phone: 702-906-1100 Fax: 702-906-1110 |